Current Grants and Funding
|
- Susan G. Komen Breast Cancer Foundation Grant: ‘Combining vaccines and adoptive T cell transfer for breast cancer immunotherapy’, 2007–10.
- Bob Parker Memorial Foundation Grant: $100,000 pa, ‘Developing improved immunotherapies for kidney cancer’, 2008–10.
- NHMRC Career Development Award: $102,000 p.a., Darcy PK. Development of cancer immunotherapy using gene-engineered T cells in a self-antigen mouse model 2009–12.
- NHMRC Senior Research Fellowship: $112,000 pa, Kershaw, M, 2009–13.
- NHMRC Career Development Award: $85,500 p.a., ‘Preclinical characterization of gene-engineered T cells for immunotherapy of cancer’, 2009–12.
- NHMRC Project Grant: $93,000 pa, 'Generating Tumour-Specific Dendritic Cells for Cancer Therapy' 2007–09.
- Pfizer: $90,000, 'Ultrasound-guided intratumoral delivery of CpG combined with anti-4-1BB for the treatment of orthotopic cancer in mouse models', 2009.
- NHMRC Project Grant: $145,000 pa, 'An integrated approach for the adoptive immunotherapy of cancer', 2008–10.
|
|
Recent Grants and Funding
|
- National Breast Cancer Foundation (NBCF) and NHMRC Career Development Award: $85,000 pa, ‘The development of effective immunotherapies for cancer’, 2004–08.
- NHMRC Career Development Award: $85,500 pa, ‘Preclinical characterization of gene-engineered T cells for immunotherapy of cancer’, 2004–08.
- NHMRC Project Grant: $92,250 pa, ‘Generating tumour-specific dendritic cells for cancer therapy, 2007–09.
- Cancer Council of Victoria Grant in Aid: $70,000 pa, ’Immunotherapy of Lewis Y+ malignancy using genetically engineered T cells’ 2007–09.
|
|
 |
|
